Biohaven completes enrollment in focal epilepsy drug trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. DHR
2. NOW
3. USO
4. NVDA
5. SPY
6. AMD
7. SMCI
8. GOOGL
9. TSLA
10. GM

Go back to Biohaven completes enrollment in focal epilepsy drug trial
(NYSE: BHVN) Delayed: 14.75 -0.76 (4.9%)
Previous Close $15.51    52 Week High $ 
Open $15.26    52 Week Low $ 
Day High $15.50    P/E N/A 
Day Low $14.56    EPS $ 
Volume 2,169,531